Commentary to "Dosing vitamin C in critically ill patients with special attention to renal replacement therapy: a narrative review".
作者信息
Morán J M, Herrera-Peco I
机构信息
Nursing and Occupational Therapy College, Nursing Department, University of Extremadura, Cáceres, Spain.
Faculty of Health Sciences, Alfonso X El Sabio University, Villanueva de la Cañada, Madrid, Spain.
出版信息
Ann Intensive Care. 2020 Jul 6;10(1):87. doi: 10.1186/s13613-020-00710-7.
Abstract
摘要
相似文献
1
Commentary to "Dosing vitamin C in critically ill patients with special attention to renal replacement therapy: a narrative review".《重症患者维生素C给药，特别关注肾脏替代治疗：叙述性综述》述评
Ann Intensive Care. 2020 Jul 6;10(1):87. doi: 10.1186/s13613-020-00710-7.
2
Dosing vitamin C in critically ill patients with special attention to renal replacement therapy: a narrative review.重症患者维生素C给药，尤其关注肾脏替代治疗：一篇叙述性综述。
Ann Intensive Care. 2020 Feb 12;10(1):23. doi: 10.1186/s13613-020-0640-6.
3
Antibiotic Dosing for Critically Ill Adult Patients Receiving Intermittent Hemodialysis, Prolonged Intermittent Renal Replacement Therapy, and Continuous Renal Replacement Therapy: An Update.重症成人患者接受间歇性血液透析、延长间歇性肾脏替代治疗和持续肾脏替代治疗时的抗生素剂量：更新。
Ann Pharmacother. 2020 Jan;54(1):43-55. doi: 10.1177/1060028019865873. Epub 2019 Jul 25.
4
Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis.接受持续肾脏替代疗法或间歇性血液透析的成年危重症患者的抗菌药物给药概念及建议
Pharmacotherapy. 2009 May;29(5):562-77. doi: 10.1592/phco.29.5.562.
5
Drug Dosing Considerations in Critically Ill Patients Receiving Continuous Renal Replacement Therapy.接受持续肾脏替代治疗的重症患者的药物剂量考量
Pharmacy (Basel). 2020 Feb 7;8(1):18. doi: 10.3390/pharmacy8010018.
6
The impact of variation in renal replacement therapy settings on piperacillin, meropenem, and vancomycin drug clearance in the critically ill: an analysis of published literature and dosing regimens*.肾脏替代治疗方案中的变异性对危重症患者哌拉西林、美罗培南和万古霉素药物清除率的影响：文献分析和剂量方案*。
Crit Care Med. 2014 Jul;42(7):1640-50. doi: 10.1097/CCM.0000000000000317.
7
Quality of pharmacokinetic studies in critically ill patients receiving continuous renal replacement therapy.连续性肾脏替代治疗危重症患者药代动力学研究的质量。
Acta Anaesthesiol Scand. 2012 Feb;56(2):147-57. doi: 10.1111/j.1399-6576.2011.02571.x. Epub 2011 Oct 19.
8
Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study.连续性肾脏替代治疗的危重症患者的抗生素浓度变异性：一项多中心药代动力学研究。
Crit Care Med. 2012 May;40(5):1523-8. doi: 10.1097/CCM.0b013e318241e553.
9
Dosing adjuvant vitamin C in critically ill patients undergoing continuous renal replacement therapy: We are not there yet!在接受持续肾脏替代治疗的重症患者中给予辅助维生素C：我们尚未达到目标！
Crit Care. 2019 Jan 9;23(1):5. doi: 10.1186/s13054-018-2297-1.
10
Role of renal function in risk assessment of target non-attainment after standard dosing of meropenem in critically ill patients: a prospective observational study.肾功能在标准剂量美罗培南治疗危重症患者后目标未达标风险评估中的作用：一项前瞻性观察研究。
Crit Care. 2017 Oct 21;21(1):263. doi: 10.1186/s13054-017-1829-4.
引用本文的文献
1
Response to the letter of Morán et al. regarding our use of an inaccurate reference for the maximal dose of vitamin C in G6PD deficiency.对莫兰等人来信的回复，信中涉及我们在G6PD缺乏症中使用维生素C最大剂量的不准确参考文献的问题。
Ann Intensive Care. 2020 Jul 10;10(1):93. doi: 10.1186/s13613-020-00712-5.
本文引用的文献
1
Dosing vitamin C in critically ill patients with special attention to renal replacement therapy: a narrative review.重症患者维生素C给药，尤其关注肾脏替代治疗：一篇叙述性综述。
Ann Intensive Care. 2020 Feb 12;10(1):23. doi: 10.1186/s13613-020-0640-6.
2
Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical Trial.维生素 C、氢化可的松和硫胺素与单独使用氢化可的松对感染性休克患者存活时间和脱离血管加压支持的影响：VITAMINS 随机临床试验。
JAMA. 2020 Feb 4;323(5):423-431. doi: 10.1001/jama.2019.22176.
3
Hemolytic jaundice induced by pharmacological dose ascorbic acid in glucose-6-phosphate dehydrogenase deficiency: A case report: Retraction.葡萄糖-6-磷酸脱氢酶缺乏症患者因药理剂量维生素C诱导的溶血性黄疸：一例报告：撤回声明
Medicine (Baltimore). 2019 Nov;98(48):e18261. doi: 10.1097/MD.0000000000018261.
4
Hemolytic jaundice induced by pharmacological dose ascorbic acid in glucose-6-phosphate dehydrogenase deficiency: A case report.葡萄糖-6-磷酸脱氢酶缺乏症患者因药理学剂量的抗坏血酸诱发的溶血性黄疸：一例报告
Medicine (Baltimore). 2018 Dec;97(51):e13588. doi: 10.1097/MD.0000000000013588.
Zotero 插件